Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Teleflex Incorporated (NYSE:TFX) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $252.50.

Several research analysts have recently weighed in on TFX shares. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho dropped their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Truist Financial lowered their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th.

Teleflex Stock Up 0.1 %

Shares of NYSE:TFX opened at $181.56 on Friday. Teleflex has a 12-month low of $171.69 and a 12-month high of $256.85. The stock has a market capitalization of $8.43 billion, a price-to-earnings ratio of 36.10, a PEG ratio of 1.64 and a beta of 1.16. The stock has a fifty day simple moving average of $184.14 and a two-hundred day simple moving average of $215.47. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex’s revenue was up 2.4% compared to the same quarter last year. During the same period last year, the business earned $3.64 EPS. On average, research analysts anticipate that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.75%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Hedge Funds Weigh In On Teleflex

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Asset Management L.P. raised its stake in shares of Teleflex by 564.3% in the second quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock worth $65,304,000 after buying an additional 263,743 shares during the period. Janus Henderson Group PLC lifted its holdings in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. FMR LLC boosted its position in shares of Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares during the period. Kimelman & Baird LLC purchased a new stake in shares of Teleflex in the second quarter worth $21,232,000. Finally, Assenagon Asset Management S.A. raised its position in shares of Teleflex by 457.6% during the 3rd quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock valued at $29,755,000 after purchasing an additional 98,735 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.